Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Droplet Digital PCR for Oncogenic KMT2A Fusion Detection
Andrew L. Young
, Hannah C. Davis
,
Grant A. Challen
Division of Hematology
Institute of Clinical and Translational Sciences (ICTS)
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
DBBS - Cancer Biology
DBBS - Developmental, Regenerative and Stem Cell Biology
DBBS - Molecular Cell Biology
DBBS - Molecular Genetics and Genomics
Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Center of Regenerative Medicine
Siteman Cancer Center
Section of Stem Cell Biology
Research output
:
Contribution to journal
›
Article
›
peer-review
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Droplet Digital PCR for Oncogenic KMT2A Fusion Detection'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Droplet Digital PCR (ddPCR)
100%
Fusion Detection
100%
KMT2A
100%
Acute Myeloid Leukemia
80%
Treatment Decisions
40%
Chemotherapy Exposure
40%
Oncogenic Fusion
40%
Therapy-related AML
40%
Disease Diagnosis
20%
DNA Sequencing
20%
Flow Cytometry
20%
PCR Assay
20%
Radiation Exposure
20%
Limit of Detection
20%
Cell Morphology
20%
Blood Cancer
20%
Fusion Partner
20%
Patient Samples
20%
Acute Myeloid Leukemia Cells
20%
Prior Treatment
20%
Disease Treatment
20%
Treatment-resistant
20%
DNA Double-strand Breaks
20%
Leukemic Cells
20%
Residual Disease
20%
KMT2A Rearrangement
20%
At-risk Individuals
20%
T-AML
20%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Carcinogenesis
100%
Droplet Digital Polymerase Chain Reaction
100%
KMT2A
100%
Acute Myelogenous Leukemia
33%
Decision Making
33%
Leukemia Cell
16%
DNA Sequence
16%
Flow Cytometry
16%
Cell Line
16%
Radiation Exposure
16%
Hematological Cancer
16%
Minimal Residual Disease
16%
Prognostication
16%
Diseases
16%
Double-Strand DNA Break
16%
Biochemistry, Genetics and Molecular Biology
Carcinogenesis
100%
Myeloid
100%
Droplet Digital Polymerase Chain Reaction
100%
KMT2A
100%
Decision Making
33%
DNA Sequence
16%
Flow Cytometry
16%
Double-Strand DNA Break
16%